Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Propolis, a resinous substance produced by bees, has been traditionally used in various cultures for its purported antimicrobial and anti-inflammatory properties. In the context of bronchitis, there is some scientific evidence supporting its use, though the quality and quantity of research are limited. Several in vitro and animal studies have demonstrated that propolis possesses antimicrobial activity against pathogens commonly implicated in respiratory tract infections. In addition, its anti-inflammatory effects may help reduce airway inflammation associated with bronchitis.

A few small clinical trials have investigated propolis as an adjunct treatment for acute and chronic bronchitis. For example, a randomized controlled trial published in Phytomedicine (2003) showed that propolis extract, when used alongside standard therapy, improved symptoms and reduced the duration of acute bronchitis compared to placebo. However, these studies often suffer from methodological limitations, such as small sample sizes and lack of blinding.

Overall, while there is preliminary scientific validation for the use of propolis in managing bronchitis, the evidence base is not strong. Larger, well-designed clinical trials are needed to confirm its efficacy and safety. Until then, propolis may be considered as a complementary option, but not a replacement for established medical treatments.

More about Propolis
More about Bronchitis

Other ingredients used for Bronchitis

Other health conditions supported by Propolis

Products containing Propolis